Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "NCEs"

2163 News Found

Medtronic announces launch of Open Innovation Platform for APAC
Digitisation | October 20, 2021

Medtronic announces launch of Open Innovation Platform for APAC

The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology


Alcon announces launch of AcrySof IQ Vivity in India,
Medical Device | October 19, 2021

Alcon announces launch of AcrySof IQ Vivity in India,

It is the first presbyopia-correcting lens implant for cataract surgery


Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules
Drug Approval | October 19, 2021

Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules

The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg


AUM Biosciences closes US $ 27 million `Series A’ funding round
Startup | October 15, 2021

AUM Biosciences closes US $ 27 million `Series A’ funding round

Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate


HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
Digitisation | October 12, 2021

HCL expands its partnership with Google Cloud to focus on healthcare and life sciences

HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs


Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million


Janssen announces novel mechanism that shows promise against dengue
Biotech | October 07, 2021

Janssen announces novel mechanism that shows promise against dengue

Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats


Natco announces launch of 10 mg Everolimus in the US
Drug Approval | October 01, 2021

Natco announces launch of 10 mg Everolimus in the US

According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021


NASSCOM CoE-IoT announces winners of Healthcare Innovation challenge
Healthcare | October 01, 2021

NASSCOM CoE-IoT announces winners of Healthcare Innovation challenge

This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption


Carmat announces first implant of its artificial heart in a woman
Healthcare | September 21, 2021

Carmat announces first implant of its artificial heart in a woman

The recipient is a 57-year-old woman who was suffering from severe biventricular heart failure and had undergone cardiac surgery several years ago